参考文献/References:
[1] Gao B, Doan A, Hybertson BM. The clinical potential of influencing Nrf2 signaling in degenerative andimmunological disorders[J].Clin Pharmacol,2014,6:19-34. DOI: 10.2147/CPAA.S35078.
[2] Ma L, Liu X, Zhao Y,et al. Ginkgolide B reduces LOX-1 expression by inhibiting Akt phosphorylation andincreasing Sirt1 expression in oxidized LDL-stimulated human umbilical vein endothelial cells[J].PLoS One,2013,8(9):e74769. DOI: 10.1371/journal.pone.0074769.
[3] Sato K, Yama K, Murao Y, et al. Epalrestat increases intracellular glutathione levels in Schwann cells through transcription regulation[J].Redox Biol,2013,2:15-21. DOI: 10.1016/j.redox.2013.11.003.
[4] 潘晓菲,谭初兵,时丽丽,等.Nrf2/ARE信号通路及其相关药物研究进展[J].药物评价研究,2013,36(1):54-58. DOI:10.7501/j.issn.1674-6376.2013.01.014.
[5] Jayachandran M, Chandrasekaran B, Namasivayam N. Geraniol attenuates oxidative stress by Nrf2 activation in diet-induced experimental atherosclerosis[J].J Basic Clin Physiol Pharmacol,2015,26(4):335-346. DOI: 10.1515/jbcpp-2014-0057.
[6] 吴彧,孙琳,黄彦生,等. 氧化应激与炎症在动脉粥样硬化发生发展中的作用及相关治疗药物研究[J]. 中国实用神经疾病杂志,2014,(21):127-129.DOI:10.3969/j.issn.1673-5110.2014.21.086.
[7] Donovan EL, McCord JM, Reuland DJ,et al. Phytochemical activation of Nrf2 protects human coronary artery endothelial cells against an oxidative challenge[J].Oxid Med Cell Longev,2012,2012:132931. DOI: 10.1155/2012/132931.
[8] Lee HJ, Seo M, Lee EJ. Salvianolic acid B inhibits atherogenesis of vascular cells through induction of Nrf2-dependent heme oxygenase-1[J].Curr Med Chem,2014,21(26):3095-3106.
[9] Qin X, Qiu C, Zhao L. Maslinic acid protects vascular smooth muscle cells from oxidative stress through Akt/Nrf2/HO-1 pathway[J].Mol Cell Biochem,2014,390(1-2):61-67. DOI: 10.1007/s11010-013-1956-4.
[10] Lázaro I, Ferré R, Masana L,et al. Akt and ERK/Nrf2 activation by PUFA oxidation-derived aldehydes upregulates FABP4 expression in human macrophages[J].Atherosclerosis,2013,230(2):216-222.DOI:10.1016/j.atherosclerosis.2013.07.043.
[11] 沈燕,黎红华.胰岛素抵抗导致动脉粥样硬化的机制研究[J].神经损伤与功能重建,2012,7(5):377-379. DOI:10.3870/sjsscj.2012.05.018.
[12] 宁梦丽,丁文军,张芳. Nrf2抵抗胰岛β细胞氧化损伤的作用机制[J]. 中国科学院大学学报,2015,32(3):301-308. DOI:10.7523/j.issn.2095-6134.2015.03.003.
[13] Hegab Z, Gibbons S, Neyses L,et al. Role of advanced glycation end products in cardiovascular disease[J].World J Cardiol,2012,4(4):90-102. DOI: 10.4330/wjc.v4.i4.90.
[14] Huang K, Huang J, Xie X,et al. Sirt1 resists advanced glycation end products-induced expressions of fibronectin and TGF-β1 by activating the Nrf2/ARE pathway in glomerular mesangial cells[J].Free Radic Biol Med,2013,65:528-540. DOI: 10.1016/j.freeradbiomed.2013.07.029.
[15] Lee BH, Hsu WH, Hsu YW,et al. Dimerumic acid attenuates receptor for advanced glycation endproducts signal toinhibit inflammation and diabetes mediated by Nrf2 activation and promotesmethylglyoxal metabolism into d-lactic acid[J].Free Radic Biol Med,2013,60:7-16. DOI: 10.1016/j.freeradbiomed.2013.01.030.
[16] 郑晓英. 白藜芦醇对2型糖尿病血管病变的保护作用及机制[D].重庆医科大学,2014.
[17] Tan SM, Sharma A, Stefanovic N,et al. Derivative of bardoxolone methyl, dh404, in an inverse dose-dependent manner lessensdiabetes-associated atherosclerosis and improves diabetic kidney disease[J].Diabetes,2014,63(9):3091-3103. DOI: 10.2337/db13-1743.
[18] 谢利平,顾月,孟国梁,等. 硫化氢对糖尿病动脉粥样硬化的作用及机制研究[C]. 第十二届全国脂质与脂蛋白学术会议论文汇编,杭州,2014,164.
相似文献/References:
[1]李春睿,王静,陈峰,等.GLP-1受体激动剂对糖尿病患者肾功能的影响[J].国际内分泌代谢杂志,2014,(06):401.[doi:10.3760/cma.j.issn.1673-4157.2014.06.011]
Li Chunrui*,Wang Jing,Chen Feng,et al.Effects of GLP-1 receptor agonists on renal function of diabetics[J].International Journal of Endocrinology and Metabolism,2014,(03):401.[doi:10.3760/cma.j.issn.1673-4157.2014.06.011]
[2]黄珊珊,鲁一兵.长链非编码RNA与糖尿病[J].国际内分泌代谢杂志,2015,(04):271.[doi:10.3760/cma.j.issn.1673-4157.2015.04.016]
Huang Shanshan*,Lu Yibing..Long non-coding RNA and diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(03):271.[doi:10.3760/cma.j.issn.1673-4157.2015.04.016]
[3]高瑞霄,姚朱华,冯凭,等.尿8-羟基脱氧鸟苷在2型糖尿病及糖尿病合并冠心病患者中的临床意义[J].国际内分泌代谢杂志,2014,(05):295.[doi:10.3760/cma.j.issn.1673-4157.2014.05.002]
Gao Ruixiao*,Yao Zhuhua,Feng Ping,et al.The clinical significance of urinary 8-hydroxy deoxyguanosine in patients with type 2 diabetes mellitus and diabetic patients with coronary heart disease[J].International Journal of Endocrinology and Metabolism,2014,(03):295.[doi:10.3760/cma.j.issn.1673-4157.2014.05.002]
[4]郑佳,肖新华.葡萄糖稳态的中枢调控作用机制
——2014年美国糖尿病协会“杰出科学成就奖”
演讲报告解读[J].国际内分泌代谢杂志,2014,(05):305.[doi:10.3760/cma.j.issn.1673-4157.2014.05.004]
Zheng Jia,Xiao Xinhua.The mechanisms of central nervous system in the control of glucose homeostasis--A summary of 2014 ADA "Outstanding Scientific Achievement Award" Lecture[J].International Journal of Endocrinology and Metabolism,2014,(03):305.[doi:10.3760/cma.j.issn.1673-4157.2014.05.004]
[5]唐勤,邵莉.蛋白乙酰化与胰岛素分泌[J].国际内分泌代谢杂志,2014,(05):313.[doi:10.3760/cma.j.issn.1673-4157.2014.05.007]
Tang Qin,Shao Li..Protein acetylation and insulin secretion[J].International Journal of Endocrinology and Metabolism,2014,(03):313.[doi:10.3760/cma.j.issn.1673-4157.2014.05.007]
[6]卢婷婷,任思佳,沈捷.人群迁徙对糖尿病患病率的影响及其相关因素[J].国际内分泌代谢杂志,2014,(05):327.[doi:10.3760/cma.j.issn.1673-4157.2014.05.011]
Lu Tingting,Ren Sijia,Shen Jie..Impact of migration on prevalence of diabetes and risk factors[J].International Journal of Endocrinology and Metabolism,2014,(03):327.[doi:10.3760/cma.j.issn.1673-4157.2014.05.011]
[7]包薇萍,陈国芳,刘超.DPP-4抑制剂的肾保护作用[J].国际内分泌代谢杂志,2014,(05):337.[doi:10.3760/cma.j.issn.1673-4157.2014.05.014]
Bao Weiping,Chen Guofang,Liu Chao..Renal protective effects of dipeptidyl peptidase-4 inhibitors[J].International Journal of Endocrinology and Metabolism,2014,(03):337.[doi:10.3760/cma.j.issn.1673-4157.2014.05.014]
[8]孟庆冬,陶红.巨噬细胞凋亡与糖尿病动脉粥样硬化[J].国际内分泌代谢杂志,2014,(05):340.[doi:10.3760/cma.j.issn.1673-4157.2014.05.015]
Meng Qingdong,Tao Hong..Macrophage apoptosis and diabetic atherosclerosis[J].International Journal of Endocrinology and Metabolism,2014,(03):340.[doi:10.3760/cma.j.issn.1673-4157.2014.05.015]
[9]赵荷珺 洪天配.胰高血糖素样肽-1类药物与胰腺安全性[J].国际内分泌代谢杂志,2015,(05):319.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.008]
Zhao Hejun*,Hong Tianpei..Glucagon-like peptide-1-based therapies and pancreatic safety[J].International Journal of Endocrinology and Metabolism,2015,(03):319.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.008]
[10]吕丹 李晓思 陈树春 王泽普.Betatrophin:糖尿病再生治疗的新希望[J].国际内分泌代谢杂志,2015,(05):351.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.016]
Lyu Dan*,Li Xiaosi,Chen Shuchun,et al.Betatrophin:new hope for regeneration therapy of diabetes[J].International Journal of Endocrinology and Metabolism,2015,(03):351.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.016]